Works matching IS 13406868 AND DT 2018 AND VI 25 AND IP 4

Results: 15

The long and winding road for overcoming resistance to hormone therapy in breast cancer.

Published in:

Breast Cancer (13406868), 2018, v. 25, n. 4, p. 377, doi. 10.1007/s12282-018-0876-2

By:

Saji, Shigehira

Publication type:

Article

Do you know how to get the J-START quality assurance guideline?

Published in:

Breast Cancer (13406868), 2018, v. 25, n. 4, p. 375, doi. 10.1007/s12282-018-0867-3

By:

Uematsu, Takayoshi;
Nakamura, Seigo;
Ohuchi, Noriaki

Publication type:

Article

Cyclin-dependent kinase 4/6 inhibitors as first-line treatment for post-menopausal metastatic hormone receptor-positive breast cancer patients: a systematic review and meta-analysis of phase III randomized clinical trials.

Published in:

Breast Cancer (13406868), 2018, v. 25, n. 4, p. 479, doi. 10.1007/s12282-018-0848-6

By:

Ramos-Esquivel, Allan;
Hernández-Steller, Hellen;
Savard, Marie-France;
Landaverde, Denis Ulises

Publication type:

Article

Diagnosis, characteristics, and treatment of breast carcinomas within benign fibroepithelial tumors.

Published in:

Breast Cancer (13406868), 2018, v. 25, n. 4, p. 470, doi. 10.1007/s12282-018-0847-7

By:

Saimura, Michiyo;
Koga, Kenichiro;
Anan, Keisei;
Mitsuyama, Shoshu;
Tamiya, Sadafumi

Publication type:

Article

Preoperative breast MRI: reproducibility and significance of findings relevant to nipple-areolar complex involvement.

Published in:

Breast Cancer (13406868), 2018, v. 25, n. 4, p. 456, doi. 10.1007/s12282-018-0845-9

By:

Machida, Youichi;
Shimauchi, Akiko;
Igarashi, Takao;
Hoshi, Kazuei;
Fukuma, Eisuke

Publication type:

Article

Meta-analysis for psychological impact of breast reconstruction in patients with breast cancer.

Published in:

Breast Cancer (13406868), 2018, v. 25, n. 4, p. 464, doi. 10.1007/s12282-018-0846-8

By:

Chen, Wanjing;
Lv, Xiaoai;
Xu, Xiaohong;
Gao, Xiufei;
Wang, Bei

Publication type:

Article

Effect of the normal mammary differentiation regulator ELF5 upon clinical outcomes of triple negative breast cancers patients.

Published in:

Breast Cancer (13406868), 2018, v. 25, n. 4, p. 489, doi. 10.1007/s12282-018-0842-z

By:

Omata, Fumiya;
McNamara, Keely May;
Suzuki, Koyu;
Abe, Eriko;
Hirakawa, Hisashi;
Ishida, Takanori;
Ohuchi, Noriaki;
Sasano, Hironobu

Publication type:

Article

OCT4 but not SOX2 expression correlates with worse prognosis in surgical patients with triple-negative breast cancer.

Published in:

Breast Cancer (13406868), 2018, v. 25, n. 4, p. 447, doi. 10.1007/s12282-018-0844-x

By:

Zhang, Jia-Ming;
Wei, Kai;
Jiang, Ming

Publication type:

Article

Efficacy and safety of trastuzumab, lapatinib, and paclitaxel neoadjuvant treatment with or without prolonged exposure to anti-HER2 therapy, and with or without hormone therapy for HER2-positive primary breast cancer: a randomised, five-arm, multicentre, open-label phase II trial

Published in:

Breast Cancer (13406868), 2018, v. 25, n. 4, p. 407, doi. 10.1007/s12282-018-0839-7

By:

Masuda, N.;
Toi, M.;
Yamamoto, N.;
Iwata, H.;
Kuroi, K.;
Bando, H.;
Ohtani, S.;
Takano, T.;
Inoue, K.;
Yanagita, Y.;
Kasai, H.;
Morita, S.;
Sakurai, T.;
Ohno, S.

Publication type:

Article

Bi-weekly eribulin therapy for metastatic breast cancer: a multicenter phase II prospective study (JUST-STUDY).

Published in:

Breast Cancer (13406868), 2018, v. 25, n. 4, p. 438, doi. 10.1007/s12282-018-0843-y

By:

Ohtani, Shoichiro;
Nakayama, Takahiro;
Yoshinami, Tetsuhiro;
Watanabe, Ken-ichi;
Hara, Fumikata;
Sagara, Yasuaki;
Kawaguchi, Hidetoshi;
Higaki, Kenji;
Matsunami, Nobuki;
Hasegawa, Yoshie;
Takahashi, Masato;
Mizutani, Makiko;
Morimoto, Takashi;
Sato, Masako;
Itoh, Mitsuya;
Morita, Satoshi;
Masuda, Norikazu

Publication type:

Article

Clinical utility of RT-PCR in assessing HER 2 gene expression versus traditional IHC and FISH in breast cancer patients.

Published in:

Breast Cancer (13406868), 2018, v. 25, n. 4, p. 416, doi. 10.1007/s12282-018-0840-1

By:

Suryavanshi, Moushumi;
Mehta, Anurag;
Jaipuria, Jiten;
Kumar, Dushyant;
Vishwakarma, Gayatri;
Panigrahi, Manoj Kumar;
Verma, Haristuti;
Saifi, Mumtaz;
Sharma, Sanjeev;
Tandon, Simran;
Doval, D. C.;
Das, Bhudev C.

Publication type:

Article

Correlation of FANCM expression with clinical factors in luminal B breast cancer.

Published in:

Breast Cancer (13406868), 2018, v. 25, n. 4, p. 431, doi. 10.1007/s12282-018-0841-0

By:

Wang, Yiran;
Wang, Junnan;
Long, Fei;
Wang, Ning;
Zhang, Bingbing;
Han, Huan;
Wang, Yajie

Publication type:

Article

Clinical development of CDK4/6 inhibitor for breast cancer.

Published in:

Breast Cancer (13406868), 2018, v. 25, n. 4, p. 402, doi. 10.1007/s12282-017-0827-3

By:

Iwata, Hiroji

Publication type:

Article

Mechanism of resistance to endocrine therapy in breast cancer: the important role of PI3K/Akt/mTOR in estrogen receptor-positive, HER2-negative breast cancer.

Published in:

Breast Cancer (13406868), 2018, v. 25, n. 4, p. 392, doi. 10.1007/s12282-017-0812-x

By:

Araki, Kazuhiro;
Miyoshi, Yasuo

Publication type:

Article

Overcoming aromatase inhibitor resistance in breast cancer: possible mechanisms and clinical applications.

Published in:

Breast Cancer (13406868), 2018, v. 25, n. 4, p. 379, doi. 10.1007/s12282-017-0772-1

By:

Hanamura, Toru;
Hayashi, Shin-ichi

Publication type:

Article